← Leaderboards
Conor R Cullinane
Pirouette Medical
$479,080
Attributed
$479,080
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $326.5K · FY2023–24$500K$375K$250K$125K$0
'23
'24
Funding mix
By agency
NIH$479,080 · 1
By mechanism
R43$479,080 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Opioid Antagonist”
- Andrew Gardiner · Libero Pharma Limited$6,351,015
- Ian Gurrell · Astrazeneca Pharmaceuticals, Lp$5,256,914
- Mark Sorenson · Nirsum Laboratories, Inc.$4,866,388
- Michael V. Voronkov · Serodopa Therapeutics Inc$2,946,808
- Daniel Levy · Phoenix Pharmalabs, Inc.$2,894,503
- Georgette Suidan · Cerevel Therapeutics, Llc$2,700,000
Research focus
Opioid AntagonistShapesIntuitionOpioidPathway InteractionsRisk MinimizationDesignIntramuscularMarketingNeedlestick InjuriesOpioid OverdoseHandInjectionsPortabilityAccidentsCostDoseDevicesLacerationLifeMedicalNaloxoneOpioid MortalityStress
Grant awards (3)
A Rugged, Reliable, Portable, Safe, and Simple Naloxone HCl Auto-Injector forLife-Saving Treatment of Opioid Overdose$97,580
R43 · FY2024 · DA · contact PI
A Rugged, Reliable, Portable, Safe, and Simple Naloxone HCl Auto-Injector forLife-Saving Treatment of Opioid Overdose$55,000
R43 · FY2024 · DA · contact PI
A Rugged, Reliable, Portable, Safe, and Simple Naloxone HCl Auto-Injector forLife-Saving Treatment of Opioid Overdose$326,500
R43 · FY2023 · DA · contact PI